Paper41929322
Plasma pTau217 as a Prognostic, Monitoring, and Risk-Stratification Biomarker of Clinical Progression in Lewy Body Disease.
Lorkiewicz SA and 17 others. medRxiv, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Plasma pTau217 as a Prognostic, Monitoring, and Risk-Stratification Biomarker of Clinical Progression in Lewy Body Disease. Papers, record 41929322. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41929322
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Plasma pTau217 as a Prognostic, Monitoring, and Risk-Stratification Biomarker of Clinical Progression in Lewy Body Disease.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AG081144 | NIA NIH HHS | United States | R01AG081144 | PubMed | NIH RePORTER |
| U19 AG065156 | NIA NIH HHS | United States | U19AG065156 | PubMed | NIH RePORTER |
| R01 NS107513 | NINDS NIH HHS | United States | R01NS107513 | PubMed | NIH RePORTER |
| U01 DK140939 | NIDDK NIH HHS | United States | U01DK140939 | PubMed | NIH RePORTER |
| R21 NS132101 | NINDS NIH HHS | United States | R21NS132101 | PubMed | NIH RePORTER |
| R01 AG089169 | NIA NIH HHS | United States | R01AG089169 | PubMed | NIH RePORTER |
| R01 NS115114 | NINDS NIH HHS | United States | R01NS115114 | PubMed | NIH RePORTER |
| P30 AG066515 | NIA NIH HHS | United States | P30AG066515 | PubMed | NIH RePORTER |
| R21 AG096957 | NIA NIH HHS | United States | R21AG096957 | PubMed | NIH RePORTER |
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28592453 | Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. | Neurology | 2017 | https://conductscience.org/library/papers/28592453 | PubMed |
| 2 | 18999346 | Visuospatial deficits predict rate of cognitive decline in autopsy-verified dementia with Lewy bodies. | Neuropsychology | 2008 | https://conductscience.org/library/papers/18999346 | PubMed |
| 3 | 41240920 | Diagnostic and other biomarkers of dementia with Lewy bodies: from research to clinical settings. | Lancet Neurol | 2025 | https://conductscience.org/library/papers/41240920 | PubMed |
| 4 | 41963316 | Plasma phosphorylated tau 217 detects amyloid-β in neuronal synuclein disease. | NPJ Parkinsons Dis | 2026 | https://conductscience.org/library/papers/41963316 | PubMed |
| 5 | 39583647 | Performance of plasma p-tau217 and NfL in an unselected memory clinic setting. | Alzheimers Dement (Amst) | 2024 | https://conductscience.org/library/papers/39583647 | PubMed |
| 6 | 28655337 | Long-term cognitive outcome of Alzheimer's disease and dementia with Lewy bodies: dual disease is worse. | Alzheimers Res Ther | 2017 | https://conductscience.org/library/papers/28655337 | PubMed |
| 7 | 40853684 | Concurrent Changes in Plasma Phosphorylated Tau 217, Tau PET, and Cognition in Preclinical Alzheimer Disease. | JAMA Neurol | 2025 | https://conductscience.org/library/papers/40853684 | PubMed |
| 8 | 31660655 | Pathological Influences on Clinical Heterogeneity in Lewy Body Diseases. | Mov Disord | 2020 | https://conductscience.org/library/papers/31660655 | PubMed |
| 9 | 22658286 | Rationale for use of the Clinical Dementia Rating Sum of Boxes as a primary outcome measure for Alzheimer's disease clinical trials. | Alzheimers Dement | 2013 | https://conductscience.org/library/papers/22658286 | PubMed |
| 10 | 33285015 | Plasma Phospho-Tau Identifies Alzheimer's Co-Pathology in Patients with Lewy Body Disease. | Mov Disord | 2021 | https://conductscience.org/library/papers/33285015 | PubMed |
| 11 | 40155777 | Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials. | Nat Aging | 2025 | https://conductscience.org/library/papers/40155777 | PubMed |
| 12 | 39742695 | The effect of Amyloid and Tau Co-pathology on disease progression in Lewy body dementia: A systematic review. | Parkinsonism Relat Disord | 2025 | https://conductscience.org/library/papers/39742695 | PubMed |
| 13 | 36511519 | Illusory Responses across the Lewy Body Disease Spectrum. | Ann Neurol | 2023 | https://conductscience.org/library/papers/36511519 | PubMed |
| 14 | 34151807 | Plasma Neurofilament Light Chain Predicts Cognitive Progression in Prodromal and Clinical Dementia with Lewy Bodies. | J Alzheimers Dis | 2021 | https://conductscience.org/library/papers/34151807 | PubMed |
| 15 | 41402627 | Plasma p-Tau217 and GFAP predict widespread cognitive decline in Alzheimer's disease. | J Neurol | 2025 | https://conductscience.org/library/papers/41402627 | PubMed |
| 16 | 21606904 | Factor structure of the National Alzheimer's Coordinating Centers uniform dataset neuropsychological battery: an evaluation of invariance between and within groups over time. | Alzheimer Dis Assoc Disord | 2011 | https://conductscience.org/library/papers/21606904 | PubMed |
| 17 | 32063246 | The Uniform Dataset 3.0 Neuropsychological Battery: Factor Structure, Invariance Testing, and Demographically Adjusted Factor Score Calculation. | J Int Neuropsychol Soc | 2020 | https://conductscience.org/library/papers/32063246 | PubMed |
| 18 | 33949133 | Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau. | EMBO Mol Med | 2021 | https://conductscience.org/library/papers/33949133 | PubMed |
| 19 | 41319153 | Combined use of plasma p-tau217, NfL, and GFAP predicts domain-specific cognitive decline in cognitively unimpaired and MCI individuals. | Alzheimers Dement | 2025 | https://conductscience.org/library/papers/41319153 | PubMed |
| 20 | 41312760 | Serum p-tau217 Is a Prognostic Indicator of Cognitive Impairment in Idiopathic REM Sleep Behavior Disorder. | Ann Neurol | 2026 | https://conductscience.org/library/papers/41312760 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41929322
GET https://conductscience.org/api/papers/v1/41929322/references?page=2